Dr. Shefner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
240 W Thomas Rd
Ste 400
Phoenix, AZ 85013Phone+1 602-406-6262Fax+1 602-406-6261- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolFellowship, Clinical Neurophysiology, 1988 - 1990- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1987 - 1988
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1984 - 1986
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1983 - 1984
Northwestern University The Feinberg School of MedicineClass of 1983
Certifications & Licensure
AZ State Medical License 2014 - 2026
MA State Medical License 1985 - 2017
NY State Medical License 1996 - 2016- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- America's Best Doctors Best Doctors, 2007-2016
- Sheila Essey Award for ALS Research American Academy of Neurology, ALS Association, 2014
- America's Top Doctors Castle Connolly, 2009-2014
Clinical Trials
- A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS Start of enrollment: 2005 Oct 01
- A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
- Electrical Impedance Myography as an Outcome Measure in Amyotrophic Lateral Sclerosis Clinical Trials Start of enrollment: 2007 May 01
- Join now to see all
Publications & Presentations
PubMed
- The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, Adriano Chio, Ammar Al-Chalabi, Philip Van Damme, Chris McDermott, Jonathan Glass, James Berry, Ruben P A van Eijk, Ch...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 May 1
- Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and Practice.Lewcock, J., Bennett, F., Bowser, R., Larkin, P., Bruijn, L., Wuu, J., Benatar, M., Ostrow, L., Shefner, J.> ;Annals of Neurology. 2024 Feb 1
- Harmonized standard operating procedures for administering the ALS functional rating scale-revised.Jeremy M Shefner, Tommy Bunte, Gale Kittle, Angela Genge, Leonard H van den Berg> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 Feb 1
- Join now to see all
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral SclerosisSabrina Paganoni, Michael A Elliott, Samuel Maiser, Margaret A Owegi, Stephen A Goutman, Carlayne E Jackson, Jeffrey D Rothstein, Edward J Kasarskis, Liberty Jenkins, ..., The New England Journal of Medicine
Press Mentions
NeuroSense Announces Peer-Reviewed Publication of PrimeC Phase IIa ALS Study in Amyotrophic Lateral Sclerosis and Frontotemporal DegenerationSeptember 19th, 2022- Desperate Patients Want a New ALS Drug. The FDA Is Not Sure It WorksSeptember 6th, 2022
- AcuraStem's Development Candidate AS-202 Demonstrates Excellent Safety and Potency in Preclinical Models Representing Diverse Forms of ALSDecember 15th, 2021
- Join now to see all
Hospital Affiliations
Barrow Neurological InstitutePhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
